Magusto Julie, Majdi Amine, Gautheron Jérémie
Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine (CRSA), 27 rue Chaligny, 75571 Paris cedex 12, France - Institut de Cardiométabolisme et de Nutrition (ICAN), GHU Pitié-Salpêtrière, 47-83 boulevard de l'Hôpital, 75013 Paris, France.
Biol Aujourdhui. 2020;214(1-2):1-13. doi: 10.1051/jbio/2020002. Epub 2020 Aug 10.
Continuous cell death associated with inflammation is a key trigger of disease progression notably in chronic liver diseases such as non-alcoholic steatohepatitis (NASH). Apoptosis has been studied as a potential target for reducing cell death in NASH. However, recent studies suggest that caspase inhibition is inefficient to treat NASH patients and may aggravate the disease by redirecting cells to alternative mechanisms of cell death. Alternative forms of lytic cell death have recently been identified and are known to induce strong inflammatory responses due to cell membrane permeabilization. Therefore, controlling lytic cell death modes offers new opportunities for potential therapeutic intervention in NASH. This review summarizes the underlying molecular mechanisms of apoptosis and lytic cell death modes, including necroptosis, pyroptosis and ferroptosis, and discusses their relevance in NASH.
与炎症相关的持续性细胞死亡是疾病进展的关键触发因素,在非酒精性脂肪性肝炎(NASH)等慢性肝病中尤为明显。细胞凋亡已被作为减少NASH中细胞死亡的潜在靶点进行研究。然而,最近的研究表明,抑制半胱天冬酶治疗NASH患者无效,并且可能通过将细胞重定向至其他细胞死亡机制而加重疾病。最近已鉴定出溶解性细胞死亡的替代形式,并且已知其由于细胞膜通透性而诱导强烈的炎症反应。因此,控制溶解性细胞死亡模式为NASH的潜在治疗干预提供了新机会。本综述总结了细胞凋亡和溶解性细胞死亡模式(包括坏死性凋亡、焦亡和铁死亡)的潜在分子机制,并讨论了它们在NASH中的相关性。